• Your shopping cart is empty!

PDF Preview

CLSI POCT14

Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE

Clinical and Laboratory Standards Institute, 07/27/2020

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:27/07/2020

Pages:68

File Size:1 file , 6.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.

More CLSI standard pdf

CLSI M02-A11, M07-A9, M100-S22 Package

CLSI M02-A11, M07-A9, M100-S22 Package

Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard -Eleventh Edition / Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard -Ninth Edition / Performance Standards for Antimicrobial Susceptibility Testing

$108.00 $216.42

CLSI POCT10-A2 (R2018)

CLSI POCT10-A2 (R2018)

Provider-Performed Microscopy Testing; Approved Guideline, Second Edition, POCT10A2E

$147.00 $294.28

CLSI EP24-A2 (R2018)

CLSI EP24-A2 (R2018)

Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves; Approved Guideline - Second Edition, EP24A2E

$90.00 $180.00

CLSI C58-A (R2018)

CLSI C58-A (R2018)

Assessment of Fetal Lung Maturity by the Lamellar Body Count; Approved Guideline, C58AE

$90.00 $180.00